Point-of-Care Coagulation Testing: Stepping Gently Forward
نویسندگان
چکیده
منابع مشابه
Point-of-care coagulation testing: stepping gently forward.
As a specialist in diagnostic coagulation, I am frequently faced with a patient who does not want to drive into Boston to be monitored for warfarin (coumadin) therapy at our anticoagulation clinic. This fact has not been lost on instrument manufacturers, who have produced multiple point-of-care devices for home monitoring of the prothrombin time/international normalized ratio (PT/INR). The numb...
متن کاملPoint-of-care coagulation testing and transfusion algorithms.
Patients with cardiovascular disease have an array of haemostasis disorders that predispose to the development of thrombotic and embolic disease states. These patients are often maintained on anti-thrombotic medication to prevent adverse cardiovascular events. Patients undergoing cardiac surgery also have haemostatic disorders that include their intrinsic disease state, adjunctive medication, a...
متن کاملThyroid research: stepping forward
It is eight years since Thyroid Research was launched with an aim to enhance opportunities for scientists and clinicians, working in the rapidly advancing field of thyroidology, to publish their research (Thyroid Res 1(1):1, 2008). Right from the outset, Thyroid Research aspired to become a prominent journal in thyroidology with high quality publications. Over the years, the journal has not onl...
متن کاملPoint-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants.
BACKGROUND AND PURPOSE Specific coagulation assays for non-vitamin K antagonist oral anticoagulants (NOAC) are relatively slow and often lack availability. Although specific point-of-care tests (POCT) are currently not available, NOAC are known to affect established coagulation POCT. This study aimed at determining the diagnostic accuracy of the CoaguChek POCT to rule out relevant concentration...
متن کاملPoint-of-care coagulation management in intensive care medicine
Coagulopathy in critically ill patients is common and of multifactorial origin [1]. Coagulopathy-associated risk of bleeding and the use of allogeneic blood pro ducts are independent risk factors for morbidity and mortality [2,3]. Th erefore, prompt and correct identifi cation of the underlying causes of these coagulation abnormalities is required, since each coagulation abnormality necessitate...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Chemistry
سال: 2001
ISSN: 0009-9147,1530-8561
DOI: 10.1093/clinchem/47.5.801